scispace - formally typeset
J

Julie Parkes

Researcher at University of Southampton

Publications -  84
Citations -  4039

Julie Parkes is an academic researcher from University of Southampton. The author has contributed to research in topics: Population & Liver disease. The author has an hindex of 21, co-authored 75 publications receiving 3290 citations. Previous affiliations of Julie Parkes include Southampton General Hospital.

Papers
More filters
Journal ArticleDOI

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

TL;DR: The ELF panel has good diagnostic accuracy in an independent validation cohort of patients with NAFLD and the addition of established simple markers augments the diagnostic performance across different stages of fibrosis, which will potentially allow superior stratification of patients for emerging therapeutic strategies.
Journal ArticleDOI

Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes

TL;DR: Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm.
Journal ArticleDOI

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

TL;DR: Survival analysis showed that the ELF score predicts liver outcomes, with people having the highest ELF scores being significantly more likely to have clinical outcomes than those in lower-score groups.
Journal ArticleDOI

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

TL;DR: It is shown that established blood tests for liver fibrosis can be used in primary care to stratify patients with fatty liver disease, leading to a reduction in unnecessary referrals by 80% and greatly improving the detection of cases of advanced fibrosis and cirrhosis.
Journal ArticleDOI

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

TL;DR: In pediatric patients with NAFLD, the ELF test predicted liver fibrosis stage with a high degree of sensitivity and specificity; results were superior to those reported for adults.